Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Where to for precision treatment of HNF1A-MODY?
Bonner C, Saponaro C. Bonner C, et al. Diabetologia. 2022 Nov;65(11):1825-1829. doi: 10.1007/s00125-022-05696-4. Epub 2022 Apr 12. Diabetologia. 2022. PMID: 35412067 No abstract available.
Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
Farrelly AM, Wobser H, Bonner C, Anguissola S, Rehm M, Concannon CG, Prehn JH, Byrne MM. Farrelly AM, et al. Among authors: bonner c. Diabetologia. 2009 Jan;52(1):136-44. doi: 10.1007/s00125-008-1168-8. Epub 2008 Oct 24. Diabetologia. 2009. PMID: 18949455
Identification of circulating microRNAs in HNF1A-MODY carriers.
Bonner C, Nyhan KC, Bacon S, Kyithar MP, Schmid J, Concannon CG, Bray IM, Stallings RL, Prehn JH, Byrne MM. Bonner C, et al. Diabetologia. 2013 Aug;56(8):1743-51. doi: 10.1007/s00125-013-2939-4. Epub 2013 May 15. Diabetologia. 2013. PMID: 23674172
SGLT2 inhibition and glucagon secretion in humans.
Saponaro C, Pattou F, Bonner C. Saponaro C, et al. Among authors: bonner c. Diabetes Metab. 2018 Nov;44(5):383-385. doi: 10.1016/j.diabet.2018.06.005. Epub 2018 Jun 30. Diabetes Metab. 2018. PMID: 30017776 Review.
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release.
Saponaro C, Gmyr V, Thévenet J, Moerman E, Delalleau N, Pasquetti G, Coddeville A, Quenon A, Daoudi M, Hubert T, Vantyghem MC, Bousquet C, Martineau Y, Kerr-Conte J, Staels B, Pattou F, Bonner C. Saponaro C, et al. Among authors: bonner c. Cell Rep. 2019 Aug 6;28(6):1447-1454.e4. doi: 10.1016/j.celrep.2019.07.009. Cell Rep. 2019. PMID: 31390560 Free article.
Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets.
Saponaro C, Mühlemann M, Acosta-Montalvo A, Piron A, Gmyr V, Delalleau N, Moerman E, Thévenet J, Pasquetti G, Coddeville A, Cnop M, Kerr-Conte J, Staels B, Pattou F, Bonner C. Saponaro C, et al. Among authors: bonner c. Diabetes. 2020 May;69(5):902-914. doi: 10.2337/db19-0888. Epub 2020 Jan 2. Diabetes. 2020. PMID: 31896553
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions.
Imbernon M, Saponaro C, Helms HCC, Duquenne M, Fernandois D, Deligia E, Denis RGP, Chao DHM, Rasika S, Staels B, Pattou F, Pfrieger FW, Brodin B, Luquet S, Bonner C, Prevot V. Imbernon M, et al. Among authors: bonner c. Cell Metab. 2022 Jul 5;34(7):1054-1063.e7. doi: 10.1016/j.cmet.2022.06.002. Epub 2022 Jun 17. Cell Metab. 2022. PMID: 35716660 Free PMC article.
352 results